{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:12:58Z","timestamp":1793851978432,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01943-8","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T12:13:25Z","timestamp":1756556005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Selective disruption of DNMT1\/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated\/DGKImethylated glioblastoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Jean-Maxime","family":"Besson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Etcheverry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arulraj","family":"Nadaradjane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenola","family":"Bougras-Cartron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Sebastien","family":"Frenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Chevanieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Cartron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"1943_CR1","first-page":"3","volume":"18","author":"F Hanif","year":"2017","unstructured":"Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev APJCP. 2017;18:3\u20139.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"1943_CR2","unstructured":"Tamimi AF, Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications. 2017. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470003\/."},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.2174\/0929867324666170516123206","volume":"24","author":"R Batash","year":"2017","unstructured":"Batash R, Asna N, Schaffer P, Francis N, Schaffer M. Glioblastoma multiforme, diagnosis and treatment; recent literature review. Curr Med Chem. 2017;24:3002\u20139.","journal-title":"Curr Med Chem"},{"key":"1943_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ajco.12756","volume":"14","author":"AO Sasmita","year":"2018","unstructured":"Sasmita AO, Wong YP, Ling APK. Biomarkers and therapeutic advances in glioblastoma multiforme. Asia Pac J Clin Oncol. 2018;14:40\u201351.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3390\/cancers14081940","volume":"14","author":"N Mensali","year":"2022","unstructured":"Mensali N, Inderberg EM. Emerging biomarkers for immunotherapy in glioblastoma. Cancers. 2022;14:1940.","journal-title":"Cancers"},{"issue":"22","key":"1943_CR6","first-page":"00155","volume":"S0306\u20134522","author":"AF Aldoghachi","year":"2022","unstructured":"Aldoghachi AF, Aldoghachi AF, Breyne K, Ling K-H, Cheah P-S. Recent advances in the therapeutic strategies of glioblastoma multiforme. Neuroscience. 2022;S0306\u20134522(22):00155\u201365.","journal-title":"Neuroscience"},{"key":"1943_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1186\/1471-2164-11-701","volume":"11","author":"A Etcheverry","year":"2010","unstructured":"Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics. 2010;11:701.","journal-title":"BMC Genomics"},{"key":"1943_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12967-019-1859-6","volume":"17","author":"A Clavreul","year":"2019","unstructured":"Clavreul A, Soulard G, Lem\u00e9e J-M, Rigot M, Fabbro-Peray P, Bauchet L, et al. The French glioblastoma biobank (FGB): a national clinicobiological database. J Transl Med. 2019;17:133.","journal-title":"J Transl Med"},{"key":"1943_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5334\/ojb.62\/","volume":"7","author":"D Heymann","year":"2020","unstructured":"Heymann D, Kerdraon O, Verriele V, Verhille E, Veron V, Vitre M, et al. Centre de ressources biologiques-tumoroth\u00e8que: bioresources and associated clinical data dedicated to translational research in oncology at the Institut de Canc\u00e9rologie de l\u2019Ouest, France. Open J Bioresour. 2020;7:5. https:\/\/doi.org\/10.5334\/ojb.62\/.","journal-title":"Open J Bioresour"},{"key":"1943_CR10","unstructured":"Evans R, O\u2019Neill M, Pritzel A, Antropova N, Senior A, Green T, et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv [Internet]. 2021;2021.10.04.463034. Available from: http:\/\/biorxiv.org\/content\/early\/2021\/10\/04\/2021.10.04.463034.abstract."},{"key":"1943_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.23607","volume":"123","author":"C Stresemann","year":"2008","unstructured":"Stresemann C, Lyko F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer. 2008;123:8\u201313.","journal-title":"Int J Cancer"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"40749","DOI":"10.1074\/jbc.M505593200","volume":"280","author":"BH Lee","year":"2005","unstructured":"Lee BH, Yegnasubramanian S, Lin X, Nelson WG. Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem. 2005;280:40749\u201356.","journal-title":"J Biol Chem"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.7150\/thno.9150","volume":"6","author":"M Cheray","year":"2016","unstructured":"Cheray M, Pacaud R, Nadaradjane A, Oliver L, Vallette FM, Cartron P-F. Specific inhibition of DNMT3A\/ISGF3\u03b3 interaction increases the temozolomide efficiency to reduce tumor growth. Theranostics. 2016;6:1988\u201399.","journal-title":"Theranostics"},{"key":"1943_CR14","doi-asserted-by":"publisher","first-page":"83457","DOI":"10.18632\/oncotarget.4054","volume":"8","author":"HJ Kang","year":"2017","unstructured":"Kang HJ, Yi YW, Hou S-J, Kim HJ, Kong Y, Bae I, et al. Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor. Oncotarget. 2017;8:83457\u201368.","journal-title":"Oncotarget"},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1947601910373794","volume":"1","author":"E Hervouet","year":"2010","unstructured":"Hervouet E, Vallette FM, Cartron P-F. Dnmt1\/transcription factor interactions: an alternative mechanism of DNA methylation inheritance. Genes Cancer. 2010;1:434\u201343.","journal-title":"Genes Cancer"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4161\/epi.4.7.9883","volume":"4","author":"E Hervouet","year":"2009","unstructured":"Hervouet E, Vallette FM, Cartron P-F. Dnmt3\/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics. 2009;4:487\u201399.","journal-title":"Epigenetics"},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.biochi.2014.05.005","volume":"104","author":"R Pacaud","year":"2014","unstructured":"Pacaud R, Sery Q, Oliver L, Vallette FM, Tost J, Cartron P-F. DNMT3L interacts with transcription factors to target DNMT3L\/DNMT3B to specific DNA sequences: role of the DNMT3L\/DNMT3B\/p65-NF\u03baB complex in the (de-)methylation of TRAF1. Biochimie. 2014;104:36\u201349.","journal-title":"Biochimie"},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1038\/sj.onc.1209272","volume":"25","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Hara E, Tenen DG, et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a\/b. Oncogene. 2006;25:2477\u201388.","journal-title":"Oncogene"},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.emboj.7600509","volume":"24","author":"C Brenner","year":"2005","unstructured":"Brenner C, Deplus R, Didelot C, Loriot A, Vir\u00e9 E, De Smet C, et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 2005;24:336\u201346.","journal-title":"EMBO J"},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/74055","volume":"7","author":"Y Mo","year":"2000","unstructured":"Mo Y, Vaessen B, Johnston K, Marmorstein R. Structure of the elk-1-DNA complex reveals how DNA-distal residues affect ETS domain recognition of DNA. Nat Struct Biol. 2000;7:292\u20137.","journal-title":"Nat Struct Biol"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1868-7083-5-9","volume":"5","author":"M Cheray","year":"2013","unstructured":"Cheray M, Pacaud R, Nadaradjane A, Vallette FM, Cartron P-F. Specific inhibition of one DNMT1-including complex influences tumor initiation and progression. Clin Epigenetics. 2013;5:9.","journal-title":"Clin Epigenetics"},{"key":"1943_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1943_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2217\/epi.14.18","volume":"6","author":"M Cheray","year":"2014","unstructured":"Cheray M, Nadaradjane A, Bonnet P, Routier S, Vallette FM, Cartron P-F. Specific inhibition of DNMT1\/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness. Epigenomics. 2014;6:267\u201375.","journal-title":"Epigenomics"},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","volume":"13","author":"AK Mattox","year":"2023","unstructured":"Mattox AK, Douville C, Wang Y, Popoli M, Ptak J, Silliman N, et al. The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer. Cancer Discov. 2023;13:2166\u201379.","journal-title":"Cancer Discov"},{"key":"1943_CR25","first-page":"111","volume":"3","author":"J Li","year":"2010","unstructured":"Li J, Di C, Mattox AK, Wu L, Adamson DC. The future role of personalized medicine in the treatment of glioblastoma multiforme. Pharmacogen Pers Med. 2010;3:111\u201327.","journal-title":"Pharmacogen Pers Med"},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.4103\/2152-7806.151351","volume":"6","author":"CI Ene","year":"2015","unstructured":"Ene CI, Holland EC. Personalized medicine for gliomas. Surg Neurol Int. 2015;6:S89-95.","journal-title":"Surg Neurol Int"},{"key":"1943_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl). 2016;131:803\u201320.","journal-title":"Acta Neuropathol (Berl)"},{"key":"1943_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/neuros\/nyx148","volume":"82","author":"PM Flanigan","year":"2018","unstructured":"Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, et al. Developing an algorithm for optimizing care of elderly patients with glioblastoma. Neurosurgery. 2018;82:64\u201375.","journal-title":"Neurosurgery"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3171\/2015.4.JNS142200","volume":"124","author":"R Babu","year":"2016","unstructured":"Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D, et al. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. J Neurosurg. 2016;124:998\u20131007.","journal-title":"J Neurosurg"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2176\/nmc.ra.2017-0009","volume":"57","author":"M Okada","year":"2017","unstructured":"Okada M, Miyake K, Tamiya T. Glioblastoma treatment in the elderly. Neurol Med Chir (Tokyo). 2017;57:667\u201376.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1943_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2217\/epi-2019-0169","volume":"12","author":"P-F Cartron","year":"2020","unstructured":"Cartron P-F, Cheray M, Bretaudeau L. Epigenetic protein complexes: the adequate candidates for the use of a new generation of epidrugs in personalized and precision medicine in cancer. Epigenomics. 2020;12:171\u20137.","journal-title":"Epigenomics"},{"key":"1943_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/omi.2013.0084","volume":"18","author":"J-H Chiang","year":"2014","unstructured":"Chiang J-H, Cheng W-S, Hood L, Tian Q. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature. Omics J Integr Biol. 2014;18:310\u201323.","journal-title":"Omics J Integr Biol"},{"key":"1943_CR33","doi-asserted-by":"publisher","first-page":"89607","DOI":"10.18632\/oncotarget.19171","volume":"8","author":"A Yin","year":"2017","unstructured":"Yin A, Etcheverry A, He Y, Aubry M, Barnholtz-Sloan J, Zhang L, et al. Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas. Oncotarget. 2017;8:89607\u201319.","journal-title":"Oncotarget"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/cns.12786","volume":"24","author":"A-A Yin","year":"2018","unstructured":"Yin A-A, Lu N, Etcheverry A, Aubry M, Barnholtz-Sloan J, Zhang L-H, et al. A novel prognostic six-CpG signature in glioblastomas. CNS Neurosci Ther. 2018;24:167\u201377.","journal-title":"CNS Neurosci Ther"},{"key":"1943_CR35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1471-4159.2012.07781.x","volume":"122","author":"C Happold","year":"2012","unstructured":"Happold C, Roth P, Wick W, Schmidt N, Florea A-M, Silginer M, et al. Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. J Neurochem. 2012;122:444\u201355.","journal-title":"J Neurochem"},{"key":"1943_CR36","first-page":"6487","volume":"35","author":"M-W Poon","year":"2015","unstructured":"Poon M-W, Zhuang JTF, Wong STS, Sun S, Zhang X-Q, Leung GKK. Co-expression of cytoskeletal protein adducin 3 and CD133 in neurospheres and a temozolomide-resistant subclone of glioblastoma. Anticancer Res. 2015;35:6487\u201395.","journal-title":"Anticancer Res"},{"key":"1943_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-011-0729-8","volume":"107","author":"S Sun","year":"2012","unstructured":"Sun S, Wong TS, Zhang XQ, Pu JKS, Lee NP, Day PJR, et al. Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. J Neurooncol. 2012;107:89\u2013100.","journal-title":"J Neurooncol"},{"key":"1943_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","volume":"596","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, \u017d\u00eddek A, et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596:590\u20136.","journal-title":"Nature"},{"key":"1943_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/prot.26257","volume":"89","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Applying and improving AlphaFold at CASP14. Proteins. 2021;89:1711\u201321.","journal-title":"Proteins"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"e1012253","DOI":"10.1371\/journal.pcbi.1012253","volume":"20","author":"P Bryant","year":"2024","unstructured":"Bryant P, No\u00e9 F. Improved protein complex prediction with AlphaFold-multimer by denoising the MSA profile. PLoS Comput Biol. 2024;20:e1012253.","journal-title":"PLoS Comput Biol"},{"key":"1943_CR42","doi-asserted-by":"publisher","unstructured":"Evans R, O\u2019Neill M, Pritzel A, Antropova N, Senior A, Green T, et al. Protein complex prediction with AlphaFold-Multimer. 2021. https:\/\/doi.org\/10.1101\/2021.10.04.463034.","DOI":"10.1101\/2021.10.04.463034."},{"key":"1943_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s44320-024-00019-8","volume":"20","author":"P Trepte","year":"2024","unstructured":"Trepte P, Secker C, Olivet J, Blavier J, Kostova S, Maseko SB, et al. AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Mol Syst Biol. 2024;20:428\u201357.","journal-title":"Mol Syst Biol"},{"key":"1943_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/2211-5463.13732","volume":"14","author":"J Pei","year":"2024","unstructured":"Pei J, Zhang J, Cong Q. Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma. FEBS Open Bio. 2024;14:112\u201326.","journal-title":"FEBS Open Bio"},{"key":"1943_CR45","doi-asserted-by":"publisher","first-page":"e56834","DOI":"10.15252\/embr.202356834","volume":"24","author":"C Sifri","year":"2023","unstructured":"Sifri C, Hoeg L, Durocher D, Setiaputra D. An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3-RIF1 interaction critical for shieldin activity. EMBO Rep. 2023;24:e56834.","journal-title":"EMBO Rep"},{"key":"1943_CR46","doi-asserted-by":"publisher","first-page":"13257","DOI":"10.3390\/ijms241713257","volume":"24","author":"T Kosugi","year":"2023","unstructured":"Kosugi T, Ohue M. Design of cyclic peptides targeting protein-protein interactions using alphafold. Int J Mol Sci. 2023;24:13257.","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01943-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:15:50Z","timestamp":1756898150000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01943-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01943-8","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tumors were collected from the \u201cFrench Glioblastoma Biobank FGB\u201d []. The FGB network was declared to the French Ministry of Health and Research (declaration number: DC-2011-1467, cession authorization number: AC-2017-2993). The protocols and regulations of the FGB network were approved by the CPP OUEST II ethics committee (CB 2012\/02, date of approval: 20 December 2011) and the CNIL (no. 1476342, date of approval: 10 October 2011). Plasma was collected from patients treated at the \u201cInstitut de Canc\u00e9rologie de l\u2019Ouest\u201d (ICO, ). All patients recruited gave signed and informed consent. All the samples collected and the associated clinical information were registered in the database (N\u00b0 DC-2018-3321) validated by the French research ministry. Biological resources were stored at the \u201cCentre de Ressources Biologiques-Tumoroth\u00e8que (CRB)\u201d (Institut de Canc\u00e9rologie de l\u2019Ouest, Saint-Herblain, F44800, France) [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}